Roy NK - Search Results

1

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Kunnumakkara AB, et al. Among authors: roy nk. Br J Pharmacol. 2017 Jun;174(11):1325-1348. doi: 10.1111/bph.13621. Epub 2016 Oct 21. Br J Pharmacol. 2017. PMID: 27638428 Free PMC article. Review.

2

Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far.

Bordoloi D, Roy NK, Monisha J, Padmavathi G, Kunnumakkara AB. Bordoloi D, et al. Among authors: roy nk. Recent Pat Anticancer Drug Discov. 2016;11(1):67-97. doi: 10.2174/1574892810666151020101706. Recent Pat Anticancer Drug Discov. 2016. PMID: 26537958 Review.

3

Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Kunnumakkara AB, Banik K, Bordoloi D, Harsha C, Sailo BL, Padmavathi G, Roy NK, Gupta SC, Aggarwal BB. Kunnumakkara AB, et al. Among authors: roy nk. Front Pharmacol. 2018 Aug 6;9:686. doi: 10.3389/fphar.2018.00686. eCollection 2018. Front Pharmacol. 2018. PMID: 30127736 Free PMC article. Review.

4

An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases.

Roy NK, Parama D, Banik K, Bordoloi D, Devi AK, Thakur KK, Padmavathi G, Shakibaei M, Fan L, Sethi G, Kunnumakkara AB. Roy NK, et al. Int J Mol Sci. 2019 Aug 22;20(17):4101. doi: 10.3390/ijms20174101. Int J Mol Sci. 2019. PMID: 31443458 Free PMC article. Review.

5

Potential of butein, a tetrahydroxychalcone to obliterate cancer.

Padmavathi G, Rathnakaram SR, Monisha J, Bordoloi D, Roy NK, Kunnumakkara AB. Padmavathi G, et al. Among authors: roy nk. Phytomedicine. 2015 Dec 1;22(13):1163-71. doi: 10.1016/j.phymed.2015.08.015. Epub 2015 Oct 13. Phytomedicine. 2015. PMID: 26598915 Review.

6

Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer.

Monisha J, Roy NK, Bordoloi D, Kumar A, Golla R, Kotoky J, Padmavathi G, Kunnumakkara AB. Monisha J, et al. Among authors: roy nk. Curr Drug Targets. 2017;18(2):232-253. doi: 10.2174/1389450117666160201112330. Curr Drug Targets. 2017. PMID: 26844566 Review.

7

Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer.

Roy NK, Bordoloi D, Monisha J, Padmavathi G, Kotoky J, Golla R, Kunnumakkara AB. Roy NK, et al. Curr Drug Targets. 2017;18(4):421-435. doi: 10.2174/1389450117666160307145236. Curr Drug Targets. 2017. PMID: 26953242 Review.

8

The potential role of boswellic acids in cancer prevention and treatment.

Roy NK, Deka A, Bordoloi D, Mishra S, Kumar AP, Sethi G, Kunnumakkara AB. Roy NK, et al. Cancer Lett. 2016 Jul 10;377(1):74-86. doi: 10.1016/j.canlet.2016.04.017. Epub 2016 Apr 14. Cancer Lett. 2016. PMID: 27091399 Review.

9

NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization.

Monisha J, Padmavathi G, Roy NK, Deka A, Bordoloi D, Anip A, Kunnumakkara AB. Monisha J, et al. Among authors: roy nk. Curr Pharm Des. 2016;22(27):4173-200. doi: 10.2174/1381612822666160609110231. Curr Pharm Des. 2016. PMID: 27291284 Review.

10

Butein in health and disease: A comprehensive review.

Padmavathi G, Roy NK, Bordoloi D, Arfuso F, Mishra S, Sethi G, Bishayee A, Kunnumakkara AB. Padmavathi G, et al. Among authors: roy nk. Phytomedicine. 2017 Feb 15;25:118-127. doi: 10.1016/j.phymed.2016.12.002. Epub 2016 Dec 12. Phytomedicine. 2017. PMID: 28190465 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page